ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	9/73	191/7206	0.000119952958037
ko05321	Inflammatory bowel disease (IBD)	5/73	56/7206	0.000237441476416
ko05162	Measles	6/73	120/7206	0.0012899613907
ko05164	Influenza A	7/73	167/7206	0.0014264417051
ko05161	Hepatitis B	7/73	173/7206	0.00174826570249
ko04650	Natural killer cell mediated cytotoxicity	5/73	97/7206	0.0029059919856
ko05340	Primary immunodeficiency	3/73	30/7206	0.00332806855732
ko04621	NOD-like receptor signaling pathway	6/73	157/7206	0.00497217171905
ko04668	TNF signaling pathway	5/73	120/7206	0.00718366476403
ko04612	Antigen processing and presentation	4/73	77/7206	0.00751660822533
ko05168	Herpes simplex infection	6/73	182/7206	0.0100354587466
ko04630	Jak-STAT signaling pathway	5/73	132/7206	0.0106217414539
ko05152	Tuberculosis	6/73	187/7206	0.0113760420931
ko05332	Graft-versus-host disease	2/73	18/7206	0.0139464432059
ko04658	Th1 and Th2 cell differentiation	4/73	96/7206	0.0159872828257
ko04142	Lysosome	5/73	151/7206	0.0181350713419
ko05330	Allograft rejection	2/73	24/7206	0.0241957028029
ko04622	RIG-I-like receptor signaling pathway	3/73	62/7206	0.0246300435427
ko04217	Necroptosis	5/73	178/7206	0.0338645133605
ko05320	Autoimmune thyroid disease	2/73	29/7206	0.0344584396741
ko04210	Apoptosis	5/73	180/7206	0.0352861287843
ko04660	T cell receptor signaling pathway	4/73	124/7206	0.0366021410488
ko00514	Other types of O-glycan biosynthesis	2/73	30/7206	0.0366820376111
ko05145	Toxoplasmosis	4/73	126/7206	0.0384734731859
ko04940	Type I diabetes mellitus	2/73	32/7206	0.0412896956692